Methods Comprising Cell-Derived Vesicles Patent

ChangeBridge: EPO Bulletin - Therapeutics (A61P)

Published March 25th, 2026

Detected April 1st, 2026

Summary

The European Patent Office published patent application EP3843760A1 for ProKidney IPCo, LLC covering methods comprising cell-derived vesicles. The application, filed March 25, 2026, designates all 27 EU member states plus other EPC contracting states. This is an informational patent publication notice with no immediate regulatory compliance requirements.

View original document View source feed page

What changed

The EPO published patent application EP3843760A1 titled 'Methods Comprising Cell-Derived Vesicles' for applicants ProKidney IPCo, LLC (inventors: Timothy Bertram, Deepak Jain). The application covers therapeutic methods using cell-derived vesicles (IPC A61K 35/28) with applications in neurological conditions (A61P 25/00). Designated states include all EU member states plus Switzerland, Norway, Turkey, and other EPC contracting states.

This publication does not require any action from pharmaceutical or healthcare companies. It is an informational notice regarding a patent application's availability for review. Entities should note this IP filing if they are developing competing cell-derivative therapies or wish to monitor the competitive landscape in this therapeutic area. No compliance deadlines, penalties, or mandatory actions apply to this patent publication.

Source document (simplified)

← EPO Patent Bulletin

METHODS COMPRISING CELL-DERIVED VESICLES

Publication EP3843760A1 Kind: A1 Mar 25, 2026

Applicants

ProKidney IPCo, LLC

Inventors

Bertram, Timothy, Jain, Deepak

IPC Classifications

A61K 35/28 20150101AFI20221004BHEP A61K 9/19 20060101ALI20221004BHEP A61P 25/00 20060101ALI20221004BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →